RECOMBINANT TECHNOLOGIES LLC

Company Information
Address 1090 MERIDEN WATER BURY RD, STE 1
CHESHIRE, CT, 06410-7130

http://www.recombtech.com

Information

DUNS: 849662205

# of Employees: 1


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Novel extracorporeal device Amytrapper to remove beta amyloid in Alzheimer s Disease

    Amount: $148,491.00

    Abstract Alzheimer s disease AD is the most common cause of dementia among elderly patients afflicted by neurodegenerative diseases affecting about million people worldwide and regarded as the f ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. Small molecule therapy for Alzheimer s Disease

    Amount: $1,177,007.00

    DESCRIPTION provided by applicant Alzheimerandapos s disease AD represents a progressive degenerative illness that affects the brain resulting in memory impairment The complex etiology of AD is ...

    SBIRPhase II2016Department of Health and Human Services
  3. Small molecule therapy for Alzheimer's disease

    Amount: $274,940.00

    DESCRIPTION (provided by applicant): ABSTRACT The objective of our research is to develop an effective therapy for Alzheimer's disease (AD), by using an approach that is able to concentrate, ...

    SBIRPhase I2010Department of Health and Human Services
  4. ALBUMIN CONJUGATED DETOXIFICATION DEPOT FOR BETA AMYLOID PEPTIDES

    Amount: $351,027.00

    DESCRIPTION (provided by applicant): The hallmark of Alzheimer's disease (AD) is the presence in brain of plaques, which are complex extracellular lesions composed of a central deposition of 2-amyloid ...

    SBIRPhase I2008Department of Health and Human Services
  5. Detoxification Depot for b-amyloid peptides

    Amount: $674,976.00

    DESCRIPTION (provided by applicant): The neurotoxic amyloid plaques in the brain, characteristic of Alzheimer's disease (AD), are formed by aggregation of 2 overlapping fragments (AB1-40 and AB1-42) ...

    SBIRPhase II2005Department of Health and Human Services
  6. Detoxification Depot for Beta-amyloid peptides

    Amount: $149,800.00

    DESCRIPTION (provided by applicant): The long-term goal is to develop an effective therapy for Alzheimer's disease, by using a subcutaneous hydrogel to recognize, concentrate and eliminate beta-amylo ...

    SBIRPhase I2003Department of Health and Human Services
  7. Protein Arrays: Phosphorylation-dependent Interactions

    Amount: $122,437.00

    DESCRIPTION (provided by applicant): Protein-protein interactions are central to the process of signal transduction in biological systems. Transmembrane receptor tyrosine kinase (RTKs ...

    SBIRPhase I2001Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government